These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25921840)

  • 1. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-induced pulmonary artery hypertension in a patient with compensated cardiac disease: hemodynamic and functional response to sildenafil therapy.
    Nikolaidis L; Memon N; O'Murchu B
    Tex Heart Inst J; 2015 Feb; 42(1):50-4. PubMed ID: 25873799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
    De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
    Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
    Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M
    Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
    Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
    Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF.
    Jiang R; Wang L; Zhu CT; Yuan P; Pudasaini B; Zhao QH; Gong SG; He J; Liu JM; Hu QH
    Hypertens Res; 2015 Dec; 38(12):829-39. PubMed ID: 26202179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
    Sheth A; Park JE; Ong YE; Ho TB; Madden BP
    Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
    Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
    J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
    Belyavskiy E; Ovchinnikov A; Potekhina A; Ageev F; Edelmann F
    BMC Cardiovasc Disord; 2020 Sep; 20(1):408. PubMed ID: 32912157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Human Model for the Study of Effects of Hypoxia, Exercise, and Sildenafil on Cardiac and Vascular Function in Chronic Heart Failure.
    Damy T; Hobkirk J; Walters M; Ciobanu A; Rigby AS; Kallvikbacka-Bennett A; Guellich A; Dubois-Randé JL; Hittinger L; Clark AL; Cleland JG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):229-38. PubMed ID: 25874853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.
    Lewis GD; Shah RV; Pappagianopolas PP; Systrom DM; Semigran MJ
    Circ Heart Fail; 2008 Nov; 1(4):227-33. PubMed ID: 19808296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.